UCM-13369
UCM-13369 (Compound 4b) is a NPM1 inhibitor. UCM-13369 downregulates the pathway associated with mutant NPM1 C+, and specifically recognizes the C-end DNA-binding domain of NPM1 C+. UCM-13369 induces apoptosis in AML cell lines and primary cells, that can be used for the research of AML[1].
Product Specifications
CAS Number
[2921944-77-4]
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ucm-13369.html
Solubility
10 mM in DMSO
Smiles
N[C@@H]([C@@H]1CCNCC2CC2)[C@@H](C3=CC=C(OC)C=C3)CC4=C1C5=C(N4)C=CC=C5
Molecular Formula
C25H31N3O
Molecular Weight
389.53
References & Citations
[1]Algar S, et al. Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia. JACS Au. 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Kidins220, Phosphorylated (Ser919) (Kinase D-interacting Substrate 220kD, Kidins 220, Ankyrin Repeat-rich Membrane-spanning Protein, ARMS) (Biotin)
Kidins220, Phosphorylated (Ser919) (Kinase D-interacting Substrate 220kD, Kidins 220, Ankyrin Repeat-rich Membrane-spanning Protein, ARMS) (Biotin)